3-Bromo-9,9-diphenyl-9H-fluorene | CAS:1547491-70-2

We serve 3-Bromo-9,9-diphenyl-9H-fluorene CAS:1547491-70-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromo-9,9-diphenyl-9H-fluorene

Chemical Name:3-Bromo-9,9-diphenyl-9H-fluorene
CAS.NO:1547491-70-2
Synonyms:9H-Fluorene, 3-bromo-9,9-diphenyl-
3-Bromo-9,9-Diphenylfluorene
Molecular Formula:C25H17Br
Molecular Weight:397.30600
 
Physical and Chemical Properties:
Melting point:223ºC
 
Specification:
Appearance:White-yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 3-Bromo-9,9-diphenyl-9H-fluorene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-9,9-Diphenylfluorene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9H-Fluorene, 3-bromo-9,9-diphenyl- Use and application,9H-Fluorene, 3-bromo-9,9-diphenyl- technical grade,usp/ep/jp grade.


Related News: Global Times reported that local officials had been putting up slogans in an effort to get communities to stay at home during the epidemic and to avoid people gathering together to slow and prevent the spread of the coronavirus.2,6-Dichlorobenzaldoxime manufacturer Global Times reported that local officials had been putting up slogans in an effort to get communities to stay at home during the epidemic and to avoid people gathering together to slow and prevent the spread of the coronavirus.S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate supplier Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.N-Phenyltrifluoromethanesulfonimide vendor Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.ll coronaviruses are zoonotic, meaning they are transmitted between animals and people.